Advanced Biomed Inc.
ADVB
$1.86
-$0.04-2.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.55M | 1.73M | 1.66M | 1.73M | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.50M | 2.62M | 2.54M | 2.84M | -- |
| Operating Income | -2.50M | -2.62M | -2.54M | -2.84M | -- |
| Income Before Tax | -3.04M | -2.28M | -2.78M | -3.53M | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.04 | -2.28 | -2.78 | -3.53 | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.04M | -2.28M | -2.78M | -3.53M | -- |
| EBIT | -2.50M | -2.62M | -2.54M | -2.84M | -- |
| EBITDA | -2.19M | -2.34M | -2.27M | -2.59M | -- |
| EPS Basic | -0.15 | -0.11 | -0.14 | -0.18 | -- |
| Normalized Basic EPS | -0.10 | -0.07 | -0.09 | -0.11 | -- |
| EPS Diluted | -0.15 | -0.11 | -0.14 | -0.18 | -- |
| Normalized Diluted EPS | -0.10 | -0.07 | -0.09 | -0.11 | -- |
| Average Basic Shares Outstanding | 80.00M | 80.00M | 80.00M | 79.91M | -- |
| Average Diluted Shares Outstanding | 80.00M | 80.00M | 80.00M | 79.91M | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |